Cargando…

Validation of Claims Algorithms for Progression to Metastatic Cancer in Patients with Breast, Non-small Cell Lung, and Colorectal Cancer

BACKGROUND: Validated algorithms for identifying progression to metastatic cancer could permit the use of administrative claims databases for research in this area. OBJECTIVE: To identify simple algorithms that could accurately detect cancer progression to metastatic breast, non-small cell lung, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nordstrom, Beth L., Simeone, Jason C., Malley, Karen G., Fraeman, Kathy H., Klippel, Zandra, Durst, Mark, Page, John H., Xu, Hairong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733924/ https://www.ncbi.nlm.nih.gov/pubmed/26870695 http://dx.doi.org/10.3389/fonc.2016.00018

Ejemplares similares

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study
por: Fraeman, Kathy H., et al.
Publicado: (2013)

Perspectives on Immunotherapy of Metastatic Colorectal Cancer
por: Dai, Yongjiu, et al.
Publicado: (2021)

Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients With Hemoglobin Exceeding 12 Grams Per Deciliter
por: Nordstrom, Beth L., et al.
Publicado: (2008)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Optimizing the first-line treatment for metastatic colorectal cancer
por: Cherri, Sara, et al.
Publicado: (2023)

Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases
por: Landis, Sarah H., et al.
Publicado: (2013)

The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer
por: Zhang, Chi-Hao, et al.
Publicado: (2018)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
por: Grassi, Elisa, et al.
Publicado: (2021)

Microsatellite Instability and Metastatic Colorectal Cancer – A Clinical Perspective
por: Buchler, Tomas
Publicado: (2022)

Current concepts of anti-EGFR targeting in metastatic colorectal cancer
por: Doleschal, Bernhard, et al.
Publicado: (2022)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan
por: Tahara, Makoto, et al.
Publicado: (2020)

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
por: Song, Yurong, et al.
Publicado: (2023)

Development and Validation of an Algorithm to Identify Patients with Multiple Myeloma Using Administrative Claims Data
por: Princic, Nicole, et al.
Publicado: (2016)

Trajectory of absolute neutrophil counts in patients treated with pegfilgrastim on the day of chemotherapy versus the day after chemotherapy
por: Li, Yanli, et al.
Publicado: (2016)

Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer
por: Xu, Ting, et al.
Publicado: (2020)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
por: Rosati, Gerardo, et al.
Publicado: (2021)

Metabolic Reprogramming Helps to Define Different Metastatic Tropisms in Colorectal Cancer
por: Montero-Calle, Ana, et al.
Publicado: (2022)

Bevacizumab increases the risk of anastomosis site leakage in metastatic colorectal cancer
por: Kim, Seijong, et al.
Publicado: (2022)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
por: Melosky, Barbara
Publicado: (2014)

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
por: You, Xia-Hong, et al.
Publicado: (2019)

Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer
por: Wu, Lunpo, et al.
Publicado: (2020)

Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Regorafenib in Refractory Metastatic Colorectal Cancer: A Multi-Center Retrospective Study
por: Xu, Donghao, et al.
Publicado: (2022)

Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets
por: Piran, Mehran, et al.
Publicado: (2021)

Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer
por: Chen, Yen-Cheng, et al.
Publicado: (2022)

Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report
por: De Stefano, Alfonso, et al.
Publicado: (2023)

Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
por: Forster, Stefan, et al.
Publicado: (2020)

Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine
por: Szendrői, Miklós, et al.
Publicado: (2017)

Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
por: Melosky, Barbara
Publicado: (2017)

Immunosuppressive Microenvironment Revealed by Immune Cell Landscape in Pre-metastatic Liver of Colorectal Cancer
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer
por: Shu, Yefei, et al.
Publicado: (2021)

Clinical significance of the histopathological metastatic largest lymph node size in colorectal cancer patients
por: Omeroglu, Sinan, et al.
Publicado: (2023)

Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
por: Cremolini, Chiara, et al.
Publicado: (2023)

Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements
por: Cann, Christopher G., et al.
Publicado: (2023)

The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
por: Gandini, Annalice, et al.
Publicado: (2023)

Management of metastatic colorectal cancer in patients ≥70 years - a single center experience
por: Huemer, Florian, et al.
Publicado: (2023)

“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”?
por: Kolling, Stefan, et al.
Publicado: (2020)

Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)
por: Bahl, Ankur, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2r5jcca7vdspnlm0c9kj3avhmg